# Method AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/method-ai

- Industry: Medical Devices & Equipment
- Headquarters: Boston, US
- Website: www.methodsurgical.ai
- Total disclosed funding: $20M
- Latest round: Series A (Aug 21, 2025)
- Investors on record: 2

## About

Based in the US, Method AI, Inc. develops surgical navigation solutions that use advanced imaging technology to enhance the precision of robotic surgical procedures, particularly in oncology.Method AI, Inc., founded in 2021 and headquartered in Boston, US, specializes in surgical navigation solutions. The company has undergone a strategic pivot towards enhancing its imaging capabilities. It has secured a total of USD 20.00 mn in funding, with the latest being a Series A round led by Cleveland Clinic Ventures on August 21, 2025. The funding will support the development of their novel surgical ultrasound platform.Method AI specializes in a surgical navigation platform designed to enhance the precision of robotic surgical procedures, particularly in the field of surgical oncology. The core product includes continuous deep tissue imaging and real-time guidance, allowing physicians to execute AI-generated surgical plans. This technology addresses challenges in oncology surgeries where incomplete visibility can lead to residual cancer and complications. Method AI's solutions are targeted at healthcare providers, including hospitals and surgical centers that utilize robotic endoscopes, with a primary user base of surgeons and oncologists involved in complex cancer treatments. The company primarily operates in North America and Europe, focusing on areas where advanced robotic surgery techniques are increasingly adopted.Method AI operates on a business-to-business (B2B) model, generating revenue primarily through partnerships and subscriptions with healthcare institutions that implement their surgical navigation platform. Revenue is generated from agreements for access to the platform, which may include subscription fees for ongoing software support and updates, as well as potential transaction fees linked to the usage of advanced imaging services. The company also provides training and technical support as part of their service packages, ensuring effective integration of the technology into surgical workflows. Specific pricing details have not been disclosed, as they are customized based on the needs and scale of implementation required by healthcare facilities.Method AI plans to utilize the USD 20.00 mn raised in its Series A funding in August 2025 to further develop its novel surgical ultrasound platform. The company is focused on expanding into new geographic regions, specifically targeting additional markets in Europe by 2026. The funding will support these initiatives and enhance the existing product offerings, positioning Method AI for strategic growth in the healthcare technology sector.

## Funding rounds

- Series A, Aug 21, 2025, $20M — JobsOhio, Cleveland Clinic Ventures

## Investors

- JobsOhio (https://capitalatlas.ai/funds/jobsohio) — Series A
- Cleveland Clinic Ventures (https://capitalatlas.ai/funds/cleveland-clinic-ventures) — Series A